Mosaic ImmunoEngineering (CPMV) Revenue (2010 - 2011)
Mosaic ImmunoEngineering (CPMV) posted Revenue of $47587.0 for Q4 2011, down 64.64% on a QoQ basis from $134563.0 in Q3 2011, and down 34.61% year-over-year from $72775.0 in Q4 2010.
Powered by 
Analysis
Mosaic ImmunoEngineering (CPMV) Revenue (2010 - 2011) Analysis & Trends
Mosaic ImmunoEngineering has reported Revenue for 2 years, with the latest figure at $47587.0 in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Mosaic ImmunoEngineering | 434,528.21 | 434,528.21 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Nov 30, 2011 | 47,587.00 |
| Aug 31, 2011 | 134,563.00 |
| Nov 30, 2010 | 72,775.00 |
| Aug 31, 2010 | 94,055.00 |